|
1
|
Lawton JS: Sex and gender differences in
coronary artery disease. Semin Thorac Cardiovasc Surg. 23:126–130.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Matsuzawa Y and Lerman A: Endothelial
dysfunction and coronary artery disease: Assessment, prognosis, and
treatment. Coron Artery Dis. 25:713–724. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Du F, Zhou J, Gong R, Huang X, Pansuria M,
Virtue A, Li X, Wang H and Yang XF: Endothelial progenitor cells in
atherosclerosis. Front Biosci. 17:2327–2349. 2012. View Article : Google Scholar :
|
|
4
|
Ii M: Bone marrow-derived endothelial
progenitor cells: Isolation and characterization for myocardial
repair. Methods Mol Biol. 660:9–27. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bauer SM, Goldstein LJ, Bauer RJ, Chen H,
Putt M and Velazquez OC: The bone marrow-derived endothelial
progenitor cell response is impaired in delayed wound healing from
ischemia. J Vasc Surg. 43:134–141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vasa M, Fichtlscherer S, Aicher A, Adler
K, Urbich C, Martin H, Zeiher AM and Dimmeler S: Number and
migratory activity of circulating endothelial progenitor cells
inversely correlate with risk factors for coronary artery disease.
Circ Res. 89:E1–E7. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Loomans CJ, de Koning EJ, Staal FJ,
Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B,
Rabelink TJ and van Zonneveld AJ: Endothelial progenitor cell
dysfunction: A novel concept in the pathogenesis of vascular
complications of type 1 diabetes. Diabetes. 53:195–199. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tepper OM, Galiano RD, Capla JM, Kalka C,
Gagne PJ, Jacobowitz GR, Levine JP and Gurtner GC: Human
endothelial progenitor cells from type II diabetics exhibit
impaired proliferation, adhesion, and incorporation into vascular
structures. Circulation. 106:2781–2786. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shimada K, Mokuno H, Matsunaga E, Miyazaki
T, Sumiyoshi K, Miyauchi K and Daida H: Circulating oxidized
low-density lipoprotein is an independent predictor for cardiac
event in patients with coronary artery disease. Atherosclerosis.
174:343–347. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shimada K, Mokuno H, Matsunaga E, Miyazaki
T, Sumiyoshi K, Kume A, Miyauchi K and Daida H: Predictive value of
circulating oxidized LDL for cardiac events in type 2 diabetic
patients with coronary artery disease. Diabetes Care. 27:843–844.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao S and Liu J: Association between
circulating oxidized low-density lipoprotein and atherosclerotic
cardiovascular disease. Chronic Dis Transl Med. 3:89–94. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X, Chen J, Tao Q, Zhu J and Shang Y:
Effects of ox-LDL on number and activity of circulating endothelial
progenitor cells. Drug Chem Toxicol. 27:243–255. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu Y, Wang Q, Cheng L, Wang J and Lu G:
Effect of oxidized low-density lipoprotein on survival and function
of endothelial progenitor cell mediated by p38 signal pathway. J
Cardiovasc Pharmacol. 53:151–156. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tie G, Yan J, Yang Y, Park BD, Messina JA,
Raffai RL, Nowicki PT and Messina LM: Oxidized low-density
lipoprotein induces apoptosis in endothelial progenitor cells by
inactivating the phosphoinositide 3-kinase/Akt pathway. J Vasc Res.
47:519–530. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin FY, Tsao NW, Shih CM, Lin YW, Yeh JS,
Chen JW, Nakagami H, Morishita R, Sawamura T and Huang CY: The
biphasic effects of oxidized-low density lipoprotein on the
vasculogenic function of endothelial progenitor cells. PLoS One.
10:e01239712015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu XY, Song YH, Geng YJ, Lin QX, Shan ZX,
Lin SG and Li Y: Glucose induces apoptosis of cardiomyocytes via
microRNA-1 and IGF-1. Biochem Biophys Res Commun. 376:548–552.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vanamala J, Reddivari L, Radhakrishnan S
and Tarver C: Resveratrol suppresses IGF-1 induced human colon
cancer cell proliferation and elevates apoptosis via suppression of
IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer.
10:2382010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yousefzadeh G, Masoomi M, Emadzadeh A,
Shahesmaeili A and Sheikhvatan M: The association of insulin-like
growth factor-1 with severity of coronary artery disease. J
Cardiovasc Med. 14:416–420. 2013. View Article : Google Scholar
|
|
19
|
Akturk IF, Yalcin AA, Biyik I, Caglar NT,
Isiksacan N, Sarikamis C, Uzun F, Celik O and Caglar IM: The role
of insulin-like growth factor-1 in development of coronary
no-reflow and severity of coronary artery disease in patients with
acute myocardial infarction. Postepy Kardiol Interwencyjnej.
10:12–17. 2014.PubMed/NCBI
|
|
20
|
Andreassen M, Raymond I, Kistorp C,
Hildebrandt P, Faber J and Kristensen LØ: IGF1 as predictor of all
cause mortality and cardiovascular disease in an elderly
population. Eur J Endocrinol. 160:25–31. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kaplan RC, Strickler HD, Rohan TE,
Muzumdar R and Brown DL: Insulin-like growth factors and coronary
heart disease. Cardiol Rev. 13:35–39. 2005.PubMed/NCBI
|
|
22
|
Urbanek K, Rota M, Cascapera S, Bearzi C,
Nascimbene A, De Angelis A, Hosoda T, Chimenti S, Baker M, Limana
F, et al: Cardiac stem cells possess growth factor-receptor systems
that after activation regenerate the infarcted myocardium,
improving ventricular function and long-term survival. Circ Res.
97:663–673. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thum T, Hoeber S, Froese S, Klink I,
Stichtenoth DO, Galuppo P, Jakob M, Tsikas D, Anker SD,
Poole-Wilson PA, et al: Age-dependent impairment of endothelial
progenitor cells is corrected by growth-hormone-mediated increase
of insulin-like growth-factor-1. Circ Res. 100:434–443. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fleissner F and Thum T: The IGF-1 receptor
as a therapeutic target to improve endothelial progenitor cell
function. Mol Med. 14:235–237. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Senokuchi T, Matsumura T, Sakai M, Matsuo
T, Yano M, Kiritoshi S, Sonoda K, Kukidome D, Nishikawa T and Araki
E: Extracellular signal-regulated kinase and p38 mitogen-activated
protein kinase mediate macrophage proliferation induced by oxidized
low-density lipoprotein. Atherosclerosis. 176:233–245. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kannan Y, Sundaram K, Aluganti Narasimhulu
C, Parthasarathy S and Wewers MD: Oxidatively modified low density
lipoprotein (LDL) inhibits TLR2 and TLR4 cytokine responses in
human monocytes but not in macrophages. J Biol Chem.
287:23479–23488. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tie G, Yan J, Messina JA, Raffai RL and
Messina LM: Inhibition of p38 mitogen-activated protein kinase
enhances the apoptosis induced by oxidized low-density lipoprotein
in endothelial progenitor cells. J Vasc Res. 52:361–371. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Imanishi T, Hano T, Matsuo Y and Nishio I:
Oxidized low-density lipoprotein inhibits vascular endothelial
growth factor-induced endothelial progenitor cell differentiation.
Clin Exp Pharmacol Physiol. 30:665–670. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Imanishi T, Hano T and Nishio I:
Angiotensin II potentiates vascular endothelial growth
factor-induced proliferation and network formation of endothelial
progenitor cells. Hypertens Res. 27:101–108. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Higashi Y, Pandey A, Goodwin B and
Delafontaine P: Insulin-like growth factor-1 regulates glutathione
peroxidase expression and activity in vascular endothelial cells:
Implications for atheroprotective actions of insulin-like growth
factor-1. Biochim Biophys Acta. 1832:391–399. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ji S, Ma Q, Luo X and Peng J: Protective
effect of insulin-like growth factor-1 on vascular endothelial
function in hypercholesterolemia and the underlying mechanism.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 38:36–42. 2013.(In Chinese).
PubMed/NCBI
|
|
32
|
Dimmeler S, Aicher A, Vasa M, Mildner-Rihm
C, Adler K, Tiemann M, Rütten H, Fichtlscherer S, Martin H and
Zeiher AM: HMG-CoA reductase inhibitors (statins) increase
endothelial progenitor cells via the PI 3-kinase/Akt pathway. J
Clin Invest. 108:391–397. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Haendeler J, Hoffmann J, Diehl JF, Vasa M,
Spyridopoulos I, Zeiher AM and Dimmeler S: Antioxidants inhibit
nuclear export of telomerase reverse transcriptase and delay
replicative senescence of endothelial cells. Circ Res. 94:768–775.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Peng J, Liu B, Ma QL and Luo XJ:
Dysfunctional endothelial progenitor cells in cardiovascular
diseases: Role of NADPH oxidase. J Cardiovasc Pharmacol. 65:80–87.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Luo S, Xia W, Chen C, Robinson EA and Tao
J: Endothelial progenitor cells and hypertension: Current concepts
and future implications. Clin Sci. 130:2029–2042. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bianconi V, Sahebkar A, Kovanen P,
Bagaglia F, Ricciuti B, Calabro P, Patti G and Pirro M: Endothelial
and cardiac progenitor cells for cardiovascular repair: A
controversial paradigm in cell therapy. Pharmacol Ther.
181:156–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wils J, Favre J and Bellien J: Modulating
putative endothelial progenitor cells for the treatment of
endothelial dysfunction and cardiovascular complications in
diabetes. Pharmacol Ther. 170:98–115. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Asahara T, Murohara T, Sullivan A, Silver
M, van der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM:
Isolation of putative progenitor endothelial cells for
angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kalka C, Masuda H, Takahashi T, Kalka-Moll
WM, Silver M, Kearney M, Li T, Isner JM and Asahara T:
Transplantation of ex vivo expanded endothelial progenitor cells
for therapeutic neovascularization. Proc Natl Acad Sci USA.
97:3422–3427. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu Y, Wang Q, Cheng L, Wang J, Sun X and
Lu S: IGF-1 reduces the apoptosis of endothelial progenitor cells
induced by oxidized low-density lipoprotein by the suppressing
caspase-3 activity. Cell Res. 18:S1592008. View Article : Google Scholar
|
|
41
|
Aicher A, Heeschen C, Mildner-Rihm C,
Urbich C, Ihling C, Technau-Ihling K, Zeiher AM and Dimmeler S:
Essential role of endothelial nitric oxide synthase for
mobilization of stem and progenitor cells. Nat Med. 9:1370–1376.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Friedrich EB, Walenta K, Scharlau J,
Nickenig G and Werner N: CD34/CD133+/VEGFR-2+
endothelial progenitor cell subpopulation with potent
vasoregenerative capacities. Circ Res. 98:e20–e25. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bauersachs J and Thum T: Endothelial
progenitor cell dysfunction: Mechanisms and therapeutic approaches.
Eur J Clin Invest. 37:603–606. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ma FX, Zhou B, Chen Z, Ren Q, Lu SH,
Sawamura T and Han ZC: Oxidized low density lipoprotein impairs
endothelial progenitor cells by regulation of endothelial nitric
oxide synthase. J Lipid Res. 47:1227–1237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Thum T, Fraccarollo D, Schultheiss M,
Froese S, Galuppo P, Widder JD, Tsikas D, Ertl G and Bauersachs J:
Endothelial nitric oxide synthase uncoupling impairs endothelial
progenitor cell mobilization and function in diabetes. Diabetes.
56:666–674. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Michell BJ, Griffiths JE, Mitchelhill KI,
Rodriguez-Crespo I, Tiganis T, Bozinovski S, de Montellano PR, Kemp
BE and Pearson RB: The Akt kinase signals directly to endothelial
nitric oxide synthase. Curr Biol. 9:845–848. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Withers DJ, Burks DJ, Towery HH, Altamuro
SL, Flint CL and White MF: Irs-2 coordinates Igf-1
receptor-mediated beta-cell development and peripheral insulin
signalling. Nat Genet. 23:32–40. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
48
|
Isenovic ER, Meng Y, Divald A, Milivojevic
N and Sowers JR: Role of phosphatidylinositol 3-kinase/Akt pathway
in angiotensin II and insulin-like growth factor-1 modulation of
nitric oxide synthase in vascular smooth muscle cells. Endocrine.
19:287–292. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dimmeler S, Fleming I, Fisslthaler B,
Hermann C, Busse R and Zeiher AM: Activation of nitric oxide
synthase in endothelial cells by Akt-dependent phosphorylation.
Nature. 399:601–605. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
50
|
Asahara T, Masuda H, Takahashi T, Kalka C,
Pastore C, Silver M, Kearne M, Magner M and Isner JM: Bone marrow
origin of endothelial progenitor cells responsible for postnatal
vasculogenesis in physiological and pathological
neovascularization. Circ Res. 85:221–228. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kocher AA, Schuster MD, Szabolcs MJ,
Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM and Itescu S:
Neovascularization of ischemic myocardium by human
bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis,
reduces remodeling and improves cardiac function. Nat Med.
7:430–436. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
52
|
Murohara T, Ikeda H, Duan J, Shintani S,
Sasaki K, Eguchi H, Onitsuka I, Matsui K and Imaizumi T:
Transplanted cord blood-derived endothelial precursor cells augment
postnatal neovascularization. J Clin Invest. 105:1527–1536. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Schatteman GC, Hanlon HD, Jiao C, Dodds SG
and Christy BA: Blood-derived angioblasts accelerate blood-flow
restoration in diabetic mice. J Clin Invest. 106:571–578. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hou J, Peng X, Wang J, Zhang H, Xia J, Ge
Q, Wang X, Chen X and Wu X: Mesenchymal stem cells promote
endothelial progenitor cell proliferation by secreting insulinlike
growth factor1. Mol Med Rep. 16:1502–1508. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Thum T, Fleissner F, Klink I, Tsikas D,
Jakob M, Bauersachs J and Stichtenoth DO: Growth hormone treatment
improves markers of systemic nitric oxide bioavailability via
insulin-like growth factor-I. J Clin Endocrinol Metab.
92:4172–4179. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Higashi Y, Sukhanov S, Anwar A, Shai SY
and Delafontaine P: IGF-1, oxidative stress and atheroprotection.
Trends Endocrinol Metab. 21:245–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
